The Effect of Adding Sufentanyl to Bupivacaine in Transversus Abdominis Plane Block to Reduce the Narcotic Dosage and Pain After Cesarean Delivery (TAP)

Tehran University of Medical Sciences

Status and phase: Completed; Phase 4

Conditions: Pain

Treatments: Drug: Sufentanyl

Study type: Interventional

Funder types: Other

Identifiers

NCT01516268

886

Details and patient eligibility

About

Adding sufentanyl to bupivacain in Transversus Abdominis Plane (TAP) block under ultrasound guide can reduce narcotic dosage, side effects and pain after cesarean delivery.

Enrollment: 50 patients

Sex: Female

Ages: 18 to 40 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• female 18 to 40 Years
• class ASA 1 and 2
• candidates for elective cesarean section

Exclusion criteria

• renal failure
• liver failure
• cardiac disorder
• coagulopathy
• hepatomegaly
• splenomegaly
• drug sensitivity and abuse
• morbid obesity
• smoking
• history of post operative nausea and vomiting
• motion sickness
• local hypoesthesia

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

50 participants in 2 patient groups, including a placebo group

Sufentanyl group

Active Comparator group

Description:

IN case group we add 1cc sufentanyl to 20 cc bupivacain in TAP block

Treatment:

Drug: Sufentanyl

Control group

Placebo Comparator group

Description:

In control group we add 1cc salin to 20cc bupivacain in TAP block

Treatment:

Drug: Sufentanyl